The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice
Open Access
- 3 August 2009
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 119 (8), 2388-2398
- https://doi.org/10.1172/jci37607
Abstract
Recombinant adeno-associated viruses (AAVs) have been used widely for in vivo gene therapy. However, adaptive immune responses to AAV have posed a significant hurdle in clinical application of AAV vectors. Recent advances have suggested a crucial role for innate immunity in shaping adaptive immune responses. How AAV activates innate immunity, and thereby promotes AAV-targeted adaptive immune responses, remains unknown. Here we show that AAV activates mouse plasmacytoid DCs (pDCs) via TLR9 to produce type I IFNs. In vivo, the TLR9-MyD88 pathway was crucial to the activation of CD8+ T cell responses to both the transgene product and the AAV capsid, leading to loss of transgene expression and the generation of transgene product–specific and AAV-neutralizing antibodies. We further demonstrate that TLR9-dependent activation of adaptive immunity targeting AAV was mediated by type I IFNs and that human pDCs could be activated in vitro to induce type I IFN production via TLR9. These results reveal an essential role for the TLR9-MyD88–type I IFN pathway in induction of adaptive immune responses to AAV and suggest that strategies that interfere with this pathway may improve the outcome of AAV-mediated gene therapy in humans.Keywords
This publication has 70 references indexed in Scilit:
- Mechanism of T cell tolerance induction by murine hepatic Kupffer cellsHepatology, 2008
- Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus VectorsJournal of Virology, 2008
- Adeno-Associated Virus Type 2 (AAV2) Capsid-Specific Cytotoxic T Lymphocytes Eliminate Only Vector-Transduced Cells Coexpressing the AAV2 Capsid In VivoJournal of Virology, 2007
- Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activationThe Journal of Experimental Medicine, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006
- Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune ResponseImmunity, 2006
- A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNANature Immunology, 2005
- Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon inductionNature, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Cross-priming of CD8+ T cells stimulated by virus-induced type I interferonNature Immunology, 2003